ProofPilot Welcomes Roslyn Schneider to Advisory Board

FacebookFacebookTwitterTwitterEmailEmailLinkedInLinkedInWhatsAppWhatsAppMessengerMessengerFlipboardFlipboardGmailGmailTelegramTelegramShareShare

NEW YORK, Oct. 9, 2024 /PRNewswire/ — ProofPilot, the industry’s first end-to-end Clinical Experience Platform (CXP), purpose-built for recruitment and engagement for all study stakeholders, is thrilled to announce the addition of Dr. Roslyn Schneider, Principal, RozMD Patient Affairs Consulting LLC to its Strategic Advisory Board.

Roslyn brings over 30 years of experience as a physician, biopharmaceutical executive, and consultant, known for launching blockbuster therapies and advancing patient-centered healthcare. A retired Professor of Medicine, she is a global presenter, award-winning author, and chairs the New Jersey Chapter of the American Lung Association.

“Roslyn’s deep understanding of both the pharmaceutical industry and patient-focused healthcare aligns perfectly with ProofPilot’s mission. Having worked with leading pharmaceutical companies like Pfizer, she knows firsthand the complexities of clinical trials and will help us shape solutions that meet the evolving needs of our clients,” said Chris Venezia, CEO of ProofPilot.

At ProofPilot, Roslyn will play a crucial role in advising on product direction and strategy, ensuring that the needs of patients remain at the forefront of the clinical trial process. Her expertise in patient affairs will contribute to developing innovative solutions that enhance patient engagement and recruitment, ultimately improving trial outcomes.

Roslyn Schneider stated, “Joining ProofPilot feels like a natural extension of my passion for putting patients first. I look forward to leveraging my experience to help shape strategies that not only advance clinical development but also make a real difference in patients’ lives.”

ProofPilot will continue to announce new members of its Strategic Advisory Board, ensuring its solutions deliver immediate and long-term value for all stakeholders.

About ProofPilot

ProofPilot enhances clinical trials with its Clinical Experience Platform. The StudyCoPilot platform centralizes and simplifies communication for sponsors, patients, and sites across the clinical trial experience. Learn more at: https://www.proofpilot.com.

Media Contact: Colleen yang, colleen@proofpilot.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/proofpilot-welcomes-roslyn-schneider-to-advisory-board-302271559.html

SOURCE ProofPilot

Staff

Recent Posts

Mobile-health Network Solutions Announces Share Repurchase Program of up to 214,000 Shares

Singapore, Singapore--(Newsfile Corp. - June 5, 2025) - Mobile-health Network Solutions (NASDAQ: MNDR) ("MNDR" or…

3 hours ago

Artelo’s Fatty Acid Binding Protein 5 Inhibitor, ART26.12, Compares Favorably to Naproxen in an Osteoarthritis Pain Study

SOLANA BEACH, Calif., June 05, 2025 (GLOBE NEWSWIRE) -- Artelo Biosciences, Inc. (Nasdaq: ARTL), a…

3 hours ago

Doheny Eye Institute Welcomes Emma Lessieur-Contreras, MD, PhD, as Principal Investigator

Dr. Lessieur-Contreras will continue her groundbreaking research on understanding the early stages of diabetic retinopathy…

3 hours ago

Precision Optics Expands Facilities to Meet Growing Backlog

Company signs lease to move corporate offices and engineering development to Littleton, MA Move allows…

3 hours ago

Cellectar Biosciences Enters into Common Stock Agreements to Raise $2.5 Million Priced at Market Under Nasdaq Rules

FLORHAM PARK, N.J., June 05, 2025 (GLOBE NEWSWIRE) -- Cellectar Biosciences, Inc. (NASDAQ: CLRB), a…

3 hours ago

SELLAS Life Sciences Expands Scientific Advisory Board with Addition of Two World-Renowned Hematology and Oncology Experts

New appointments of Drs. Philip C. Amrein and Alex Kentsis Validate Lead Galinpepimut-S and SLS009…

3 hours ago